207 related articles for article (PubMed ID: 36532017)
21. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
[TBL] [Abstract][Full Text] [Related]
22. NKG2C
Grutza R; Moskorz W; Senff T; Bäcker E; Lindemann M; Zimmermann A; Uhrberg M; Lang PA; Timm J; Cosmovici C
J Immunol; 2020 Jun; 204(11):2910-2917. PubMed ID: 32284334
[TBL] [Abstract][Full Text] [Related]
23. Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans.
Bayard C; Lepetitcorps H; Roux A; Larsen M; Fastenackels S; Salle V; Vieillard V; Marchant A; Stern M; Boddaert J; Bajolle F; Appay V; Sauce D
Eur J Immunol; 2016 May; 46(5):1168-79. PubMed ID: 26910859
[TBL] [Abstract][Full Text] [Related]
24. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
[TBL] [Abstract][Full Text] [Related]
25. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.
Mazzarino P; Pietra G; Vacca P; Falco M; Colau D; Coulie P; Moretta L; Mingari MC
Eur J Immunol; 2005 Nov; 35(11):3240-7. PubMed ID: 16224817
[TBL] [Abstract][Full Text] [Related]
26. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
[TBL] [Abstract][Full Text] [Related]
27. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.
Rölle A; Pollmann J; Ewen EM; Le VT; Halenius A; Hengel H; Cerwenka A
J Clin Invest; 2014 Dec; 124(12):5305-16. PubMed ID: 25384219
[TBL] [Abstract][Full Text] [Related]
28. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.
Wu Z; Sinzger C; Frascaroli G; Reichel J; Bayer C; Wang L; Schirmbeck R; Mertens T
J Virol; 2013 Jul; 87(13):7717-25. PubMed ID: 23637420
[TBL] [Abstract][Full Text] [Related]
29. Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals.
Nielsen CM; White MJ; Bottomley C; Lusa C; Rodríguez-Galán A; Turner SE; Goodier MR; Riley EM
J Immunol; 2015 May; 194(10):4657-67. PubMed ID: 25855356
[TBL] [Abstract][Full Text] [Related]
30. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
[TBL] [Abstract][Full Text] [Related]
31. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
[TBL] [Abstract][Full Text] [Related]
32. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection.
Rölle A; Halenius A; Ewen EM; Cerwenka A; Hengel H; Momburg F
Eur J Immunol; 2016 Oct; 46(10):2420-2425. PubMed ID: 27469079
[TBL] [Abstract][Full Text] [Related]
33. HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.
Allard M; Tonnerre P; Nedellec S; Oger R; Morice A; Guilloux Y; Houssaint E; Charreau B; Gervois N
PLoS One; 2012; 7(11):e50951. PubMed ID: 23226431
[TBL] [Abstract][Full Text] [Related]
34. Obtaining Gene-Modified HLA-E-Expressing Feeder Cells for Stimulation of Natural Killer Cells.
Alekseeva NA; Streltsova MA; Vavilova JD; Ustiuzhanina MO; Palamarchuk AI; Boyko AA; Timofeev ND; Popodko AI; Kovalenko EI
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38276503
[TBL] [Abstract][Full Text] [Related]
35. Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.
Chen KC; Stanton RJ; Banat JJ; Wills MR
J Virol; 2016 Jan; 90(6):3123-37. PubMed ID: 26739048
[TBL] [Abstract][Full Text] [Related]
36. High frequencies cytomegalovirus pp65(495-503)-specific CD8+ T cells in healthy young and elderly Chinese donors: characterization of their phenotypes and TCR Vbeta usage.
He XH; Zha QB; Liu Y; Xu LH; Chi XY
J Clin Immunol; 2006 Sep; 26(5):417-29. PubMed ID: 16850281
[TBL] [Abstract][Full Text] [Related]
37. Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.
Peppa D; Pedroza-Pacheco I; Pellegrino P; Williams I; Maini MK; Borrow P
Front Immunol; 2018; 9():474. PubMed ID: 29616021
[TBL] [Abstract][Full Text] [Related]
38. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
[TBL] [Abstract][Full Text] [Related]
39. Reduced expansion of CD94/NKG2C
Puiggros A; Blanco G; Muntasell A; Rodríguez-Rivera M; Nonell L; Altadill M; Puigdecanet E; Arnal M; Calvo X; Gimeno E; Abella E; Abrisqueta P; Bosch F; Yélamos J; Ferrer A; López-Botet M; Espinet B
Int J Lab Hematol; 2021 Oct; 43(5):1032-1040. PubMed ID: 33615729
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Evolution of the Adaptive NKG2C
Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Alari-Pahissa E; Pérez-Sáez MJ; Altadill M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M
J Immunol; 2021 Oct; 207(7):1882-1890. PubMed ID: 34470855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
